Response Adapted Assignment of the Number of Chemotherapy Cycles for the Treatment of Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Is Not Justified: Results of the RICOVER-60 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).
Title:
Response Adapted Assignment of the Number of Chemotherapy Cycles for the Treatment of Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Is Not Justified: Results of the RICOVER-60 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).
Author:
Schubert, Joerg Ziepert, Marita Lengfelder, Eva Mohren, Martin Peter, Norma Reiser, Marcel Clemens, Michael Nickenig, Christina deWit, Maike Ho, Anthony Eimermacher, Hartmut Truemper, Lorenz Hoffmann, Martin Mertelsmann, Roland Metzner, Bernd Mergenthaler, Hans-Guenther Liersch, Ruediger Duehrsen, Ulrich Balleisen, Leopold Hartmann, Frank Poeschel, Viola Schmitz, Norbert Loeffler, Markus Pfreundschuh, Michael